Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
- 28 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 15 (7), 774-780
- https://doi.org/10.1038/nm.1987
Abstract
Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration, Nature Medicine aims to bridge the gap between basic research and medical advances and is consistently ranked the number one journal by the Institute of Scientific Investigation in the Medicine, Research and Experimental category.Keywords
This publication has 42 references indexed in Scilit:
- Antagonistic lipopolysaccharides blockE. colilipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding siteCellular Microbiology, 2006
- Potential oncogenic action of tenascin-C in tumorigenesisThe International Journal of Biochemistry & Cell Biology, 2005
- Endotoxin recognition and signal transduction by the TLR4/MD2-complexMicrobes and Infection, 2004
- High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokineArthritis & Rheumatism, 2003
- Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 SignalingThe Journal of Experimental Medicine, 2003
- Pattern Recognition Receptors: Doubling Up for the Innate Immune ResponseCell, 2002
- Differences in Cellular Infiltrate and Extracellular Matrix of Chronic Diabetic and Venous Ulcers Versus Acute WoundsJournal of Investigative Dermatology, 1998
- Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 1994
- Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodiesNucleic Acids Research, 1991
- INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITISThe Lancet, 1989